Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Deal Watch: Amgen Takes Center Stage With Trio Of Transactions

Executive Summary

The big biotech enters a collaboration in cancer immunotherapy and inflammation with Xencor, acquires Dutch biotech Dezima, and licenses a c-MET inhibitor to NantWorks. Also, Sun Pharma steps in to buy InSite Vision, which had been targeted by QLT.

Advertisement

Related Content

Keeping Track: Venclexta Approved; Opdivo, Atezolizumab Seek Additional Indications
Deal Watch: GSK Accelerates TCR Collaboration With Adaptimmune
Biden’s Cancer Initiative May Intensify Industry, Government Collaboration
Start-Up Quarterly Statistics, Q3 2015
Celgene Moves Into Solid Tumors With $2.9 Billion Abraxis Acquisition

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS057143

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel